Consistently, cells lacking UBAP2L harbor increased epithelial (E-cadherin, CK-18) and decreased mesenchymal markers (N-cadherin, vimentin) (Ye et al., 2017), highlighting UBAP2L’s crucial role in regulating the metastatic potential of cancer cells. This evidence concerns the gene UBAP2L and cancer.